A new co-crystal of tetraaqua acrylato cobalt (II) complex and melamine, [Co(acr)2(H2O)4]·4MA·2DMF (acr = acrylate, MA = melamine, DMF = dimethylformamide), has been synthesized and characterized using IR, UV-Vis, thermogravimetric analysis, and single-crystal X-ray diffraction. The complex contains discrete unities of [Co(acr)2(H2O)4], melamine, and DMF linked by hydrogen bonds. Investigations evidenced that Co(II) has an octahedral stereochemistry and both acrylate ions present unidentate coordination mode. Thermal decomposition occurs in four steps and denotes that melamine is lost at high temperatures, and this indicates a greater stability that may be associated with the presence of hydrogen bonds network.
相似文献An efficient protocol for C–C coupling has been developed using three iodo-bridged copper(I) complexes as catalysts. Complexes [CuI(bpy)]2 (1), [CuI(phen)]2·DMF (2), and [CuI(Mephen)]2 (3) were successfully synthesized via solvothermal method (bpy = 2,2′-dipyridyl, phen = 1,10-phenanthroline, and Mephen = 2,9-dimethylphenanthroline). The self-coupling reaction of phenylboronic acid was selected as a model reaction to evaluate the catalytic property of the complexes. Moreover, this method tolerates various substituents on the arylboronic acids such as halogens, carbonyls, and nitro groups. It shows that the iodo-bridged Cu(I) center serves as the active site to activate molecular oxygen during the catalytic process. The result illustrates that these complexes were found to be excellent catalysts for self-coupling of arylboronic acids under mild conditions.
相似文献No high-performance thin-layer chromatography (HPTLC) techniques have been established for the determination of tedizolid phosphate (TDZP) in pharmaceutical products or physiological fluids. Therefore, a rapid and highly sensitive stability-indicating HPTLC technique has been developed for the determination of TDZP in commercial formulations with a classical univariate calibration. The HPTLC‒densitometry analysis of TDZP was carried out via chloroform‒methanol (90:10, V/V) mobile phase. The determination of TDZP was performed at the wavelength of 300 nm. The proposed HPTLC technique was linear in the range of 10‒2000 ng band‒1. In addition, the method was found to be highly accurate (% recovery = 98.53‒101.74%), precise (%CV = 0.67‒0.91%), robust (%CV = 0.83‒0.86%), highly sensitive (LOD = 3.41 ng band‒1, LOQ = 10.23 ng band‒1) for the determination of TDZP. The proposed technique was also able to detect TDZP in the presence of its degradation products under various stress conditions and it can be considered as a stability-indicating method. The proposed HPTLC technique was applied for the analysis of TDZP in its commercial formulations. The TDZP contents of commercial tablets and injection were determined as 98.41% and 101.23%, respectively. These results suggested that the proposed HPTLC technique can be applied for the routine analysis of TDZP in its commercial products and newly established formulations.
相似文献The two adsorptive stripping voltammetric approaches for detection and quantitative determination of diethyl (2E)-2-{(2E)-[1-(4-methylphenyl)imidazolidin-2-ylidene]hydrazinylidene}butanedioate (DIB)—a novel molecule of medical importance—using two sensitive sensors based on modified glassy carbon electrodes as reusable sensors, were developed for the first time. The proposed electrochemical methods are based on adsorptive/reductive behaviour of DIB at two modified carbonic electrodes: a bismuth film-modified glassy carbon electrode (BiF/GCE) and a lead film-modified glassy carbon electrode (PbF/GCE). The electron gain mechanism for the electrochemical reduction of DIB on both developed sensors was proposed for the first time. To achieve the highest sensitivity in adsorptive stripping determinations, various experimental variables (e.g. the composition and pH of the supporting electrolytes, deposition conditions of bismuth and lead films, concentrations of plating solutions, accumulation times and potentials of DIB, etc.) were extensively examined. The comparison of validation parameters obtained during the determination of DIB at two sensors was presented. The excellent linear correlation was found between the monitored adsorptive stripping voltammetric peak current and the DIB concentration in the range of 15–600 μg L−1 at an accumulation time of 30 s (with LOD = 4.2 μg L−1 and LOQ = 14.0 μg L−1) using the BiF/GCE as a sensor. Furthermore, the excellent linear relationship was confirmed between the monitored adsorptive stripping voltammetric peak current and the DIB concentration in the range of 9–900 μg L−1 at an accumulation time of 10 s (with better LOD = 1.5 μg L−1 and LOQ = 5.0 μg L−1), employing the PbF/GCE as a sensor. The two optimized adsorptive stripping voltammetric approaches—as facile, sensitive, reliable and inexpensive—were successfully used as first methods for the quantitative analysis of a novel anticancer agent (DIB) in its pure pharmaceutically acceptable form. However, the practical applicability of square-wave adsorptive stripping voltammetric determination of the electroactive DIB molecule at a PbF/GCE, as the modified electrode of higher sensitivity, was presented after its successful solid phase extraction from a real serum sample.
相似文献